Sequent Scientific Ltd.
Snapshot View

106.95 +2.85 ▲2.7%

12 August 2022, 04:11:06 PM
Volume: 1,604,919

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sequent.in
Market Cap 2,666.44 Cr.
Enterprise Value(EV) 2,923.33 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.06 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 101.29 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 27.55 Trailing Twelve Months Ending 2022-06
Price to Book Value 3.88 Calculated using Price: 106.90
Dividend Yield 0.47 Period Ending 2021-03
No. of Shares Subscribed 24.94 Cr. 249,433,495 Shares
FaceValue 2
Company Profile
Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd. Pursuant to the Scheme of Amalgamation as approved by the Honourable High Court Bombay vide its order dated June 16, 2009 Company made requisite application to the Registrar of Companies Mumbai for change of its name from PI Drugs & Pharmaceuticals Ltd. to Sequent Scientific Ltd. Accordingly Registrar of Companies approved the application and issued fresh Certificate of Incorporation consequent upon change in name dated October 27, 2009 and with effect from the date the name of Company changed to Sequent Scientific Ltd.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.74%
1 Week
-14.85%
1 Month
+3.94%
3 Month
-4.85%
6 Month
-26.62%
1 Year
-59.75%
2 Year
-17.76%
5 Year
-2.46%
10 Year
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -62.91 -201.83 -28.10 -3.35 -1.74 54.15 8.63 12.06 15.00
Return on Capital Employed (%) -9.86 -16.09 6.93 2.72 0.87 41.28 9.24 12.59 16.25
Return on Assets (%) -11.23 -18.19 -1.52 -1.33 -0.95 26.54 4.14 5.73 7.19

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 95 57 91 946 977 648 707 687 728 692
Non Curr. Liab. 144 159 278 300 246 227 215 216 153 160
Curr. Liab. 345 405 406 290 664 431 440 515 514 512
Minority Int. 5 5 147 2 17 37 40 45 49 48
Equity & Liab. 589 626 922 1,538 1,904 1,343 1,402 1,463 1,443 1,412
Non Curr. Assets 358 360 612 1,047 1,176 805 796 739 676 626
Curr. Assets 231 266 310 491 728 538 606 724 767 787
Misc. Exp. not W/O
Total Assets 589 626 922 1,538 1,904 1,343 1,402 1,463 1,443 1,412

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 327 455 465 625 684 1,031 1,039 1,179 1,362 1,434
Other Income 5 4 10 14 11 17 9 10 8 9
Total Income 332 459 475 639 695 1,048 1,048 1,189 1,370 1,443
Total Expenditure -343 -439 -445 -568 -643 -919 -914 -1,009 -1,150 -1,342
PBIDT -11 21 30 71 52 129 134 180 220 100
Interest -33 -39 -44 -39 -28 -40 -33 -36 -24 -20
Depreciation -29 -33 -33 -46 -40 -53 -42 -51 -51 -51
Taxation 8 -1 -3 -3 0 -13 -2 -12 -32 1
Exceptional Items -59 38 409 -9 -3
PAT -65 -110 -12 -16 -16 431 57 82 104 28
Minority Interest 1 -2 3 -9 -8 -12 -9 -2
Share Associate
Other Related Items
Consolidated Net Profit -65 -110 -11 -18 -14 422 49 70 95 26
Adjusted EPS -6 -8 -1 -1 -1 17 2 3 4 1

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 21 -4 -45 -24 0 -7 45 116 115 115
Cash Fr. Inv. -67 -55 -80 -155 -316 -116 7 -68 -72 10
Cash Fr. Finan. 62 35 146 179 309 147 -57 -20 -43 -139
Net Change 17 -24 21 1 -7 24 -5 28 0 -14
Cash & Cash Eqvt 27 3 23 22 20 44 40 68 68 54

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 54.87 54.51 53.86 53.86 53.86 53.52 53.02 53.02 52.79
Public 45.13 45.49 46.14 46.14 46.14 46.48 46.98 46.98 47.21
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 44.60 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 11 Aug 2022
Newspaper Advertisements
Sequent Scientific Limited has informed the Exchange about Newspaper Advertisement published on August 10, 2022, in ???Financial Express??? and ???Mumbai Lakshadeep??? newspaper providing Extracts of Unaudited Financial Results of the Company for the quarter ended June 30, 2022.
Wed, 10 Aug 2022
General updates
Sequent Scientific Limited has informed the Exchange that the Board of Directors at their meeting held on August 08, 2022, has re-constituted the ???Materiality Committee??? of the Company with effect from August 08, 2022.
Wed, 10 Aug 2022
Newspaper Advertisements
Sequent Scientific Limited has informed the Exchange about Newspaper Advertisement published on August 10, 2022, in ???Financial Express??? and ???Mumbai Lakshadeep??? newspaper providing Extracts of Unaudited Financial Results of the Company for the quarter ended June 30, 2022.

Technical Scans View Details >>

Fri, 12 Aug 2022
High Decrease 6 Months High Decrease 6 Months
High Decrease 1 Year High Decrease 1 Year
Closing Near 50 SMA Closing Near 50 SMA
CCI Oversold Zone CCI Oversold Zone
Thu, 11 Aug 2022
Closing Below Previous Low Closing Below Previous Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%

FAQ's On Sequent Scientific Ltd.

Can I Buy Sequent Scientific Shares now?

What is the Share Price of Sequent Scientific?

What is the Relative Strength Index (RSI) Value of Sequent Scientific?

What is the Market Capital (MCAP) of Sequent Scientific?

What are the key metrics to analyse Sequent Scientific?

What is the Price Performance of Sequent Scientific?